Apolipoprotein E knock-out and knock-in mice: Atherosclerosis, metabolic syndrome, and beyond

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Pendse, Avani A ^a   Arbones Mainar, Jose M ^a   Johnson, Lance A ^a   Altenburg, Michael K ^a   Maeda, Nobuyo ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose tissue; Apolipoprotein E isoforms; Diabetes

Indexed keywords

APOLIPOPROTEIN E; ISOPROTEIN;

ADIPOCYTE; ANIMAL; ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; GENETICS; HUMAN; METABOLIC SYNDROME X; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ADIPOCYTES; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIABETES MELLITUS; HUMANS; METABOLIC SYNDROME X; MICE; MICE, TRANSGENIC; PROTEIN ISOFORMS;

EID: 66349121082     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800070-JLR200     Document Type: Review

References (50)

1. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
2. Havel, R. J., and J. P. Kane. 1989. Introduction: structure and metabolism of plasma lipoproteins. In The Metabolic Basis of Inherited Disease. C. S. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1129-1138.
3. Miller, N. E. 1982. Coronary atherosclerosis and plasma lipoproteins: epidemiology and pathophysiologic consideons. J. Cardiovasc. Pharmacol. 4: S190-S195. (Pubitemid 12117086)
4. Smithies, O., R. G. Gregg, S. S. Boggs, M. A. Koralewski, and R. S. Kucherlapati. 1985. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature. 317: 230-234. (Pubitemid 16246494)
5. Thomas, K. R., and M. R. Capecchi. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51:503-512.
6. Evans, M. J., and M. H. Kauffman. 1981. Establishment in culture of pleuripotent cells from mouse embryos. Nature. 292: 154-156. (Pubitemid 11050741)
7. Piedrahita, J. A., S. H. Zhang, J. R. Hagaman, P. M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89: 4471-4475.
8. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
9. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
10. Schaefer, E. J., R. E. Gregg, G. Ghiselli, T. M. Forte, J. M. Ordovas, L. A. Zech, and H. B. Brewer, Jr. 1986. Familial apolipoprotein E deficiency. J. Clin. Invest. 78: 1206-1219. (Pubitemid 17181558)
11. Ishibashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92: 883-893. (Pubitemid 23262411)
12. Rosenfeld, M. E., P. Polinsky, R. Virmani, K. Kauser, G. Rubanyi, and S. M. Schwartz. 2000. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler. Thromb. Vasc. Biol. 20: 2587-2592.
13. Williams, H., J. L. Johnson, K. G. Carson, and C. L. Jackson. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 22: 788-792.
14. nd edition. J. G. Fox, S. W. Barthold, M. T. Davisson, C. E. Newcomer, F. W. Quimby, and A. L. Smith, editors. Academic Press, Burlington, MA. 535-563.
15. Knouff, C., M. E. Hinsdale, H. Mezdour, M. K. Altenburg, M. Watanabe, S. H. Quarfordt, P. M. Sullivan, and N. Maeda. 1999. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Invest. 103: 1579-1586.
16. Sullivan, P. M., H. Mezdour, S. H. Quarfordt, and N. Maeda. 1998. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J. Clin. Invest. 102: 130-135. (Pubitemid 28323839)
17. Malloy, S. I., M. K. Altenburg, C. Knouff, L. Lanningham-Foster, J. S. Parks, and N. Maeda. 2004. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. Arterioscler. Thromb. Vasc. Biol. 24: 91-97. (Pubitemid 38082417)
18. Altenburg, M., J. Arbones-Mainar, L. Johnson, J. Wilder, andN. Maeda. 2008. Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice. Arterioscler. Thromb. Vasc. Biol. 28: 1104-1110.
19. Cullen, P., A. Cignarella, B. Brennhausen, S. Mohr, G. Assmann, and A. von Eckardstein. 1998. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J. Clin. Invest. 101: 1670-1677. (Pubitemid 28198496)
20. Hara, M., T. Matsushima, H. Satoh, N. Iso-o, H. Noto, M. Togo, S. Kimura, Y. Hashimoto, and K. Tsukamoto. 2003. Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans. Arterioscler. Thromb. Vasc. Biol. 23:269-274. (Pubitemid 36231939)
21. Lucic, D., Z. H. Huang, S. Gu de, M. K. Altenburg, N. Maeda, and T. Mazzone. 2007. Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor. J. Lipid Res. 48: 366-372. (Pubitemid 46220603)
22. Altenburg, M., L. Johnson, J. Wilder, and N. Maeda. 2007. Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner. J. Biol. Chem. 282:7817-7824. (Pubitemid 47093587)
23. Driscoll, D. M., and G. S. Getz. 1984. Extrahepatic synthesis of apolipoprotein E. J. Lipid Res. 25: 1368-1379. (Pubitemid 15150647)
24. Zechner, R., R. Moser, T. C. Newman, S. K. Fried, and J. L. Breslow. 1991. Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J. Biol. Chem. 266: 10583-10588. (Pubitemid 21906841)
25. Grundy, S. M., H. B. Brewer, Jr., J. I. Cleeman, S. C. Smith, Jr., and C. Lenfant. 2004. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler. Thromb. Vasc. Biol. 24: e13-e18.
26. Yue, L., N. Rasouli, G. Ranganathan, P. A. Kern, and T. Mazzone. 2004. Divergent effects of peroxisome proliferator-activated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expression. J. Biol. Chem. 279: 47626-47632. (Pubitemid 39540908)
27. Huang, Z. H., R. M. Luque, R. D. Kineman, and T. Mazzone. 2007. Nutritional regulation of adipose tissue apolipoprotein E expression. Am. J. Physiol. Endocrinol. Metab. 293: E203-E209. (Pubitemid 47105933)
28. Rosen, E. D., C. H. Hsu, X. Wang, S. Sakai, M. W. Freeman, F. J. Gonzalez, and B. M. Spiegelman. 2002. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 16: 22-26. (Pubitemid 34049634)
29. Schreyer, S. A., C. Vick, T. C. Lystig, P. Mystkowski, and R. C. LeBoeuf. 2002. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am. J. Physiol. Endocrinol. Metab. 282: E207-E214.
30. Chiba, T., T. Nakazawa, K. Yui, E. Kaneko, and K. Shimokado. 2003. VLDL induces adipocyte differentiation in ApoE-dependent manner. Arterioscler. Thromb. Vasc. Biol. 23: 1423-1429. (Pubitemid 36994532)
31. Hofmann, S. M., D. Perez-Tilve, T. M. Greer, B. A. Coburn, E. Grant, J. E. Basford, M. H. Tschop, and D. Y. Hui. 2008. Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice. Diabetes. 57: 5-12.
32. Gao, J., H. Katagiri, Y. Ishigaki, T. Yamada, T. Ogihara, J. Imai, K. Uno, Y. Hasegawa, M. Kanzaki, T. T. Yamamoto, et al. 2007. Involvement of apolipoprotein E in excess fat accumulation and insulin resistance. Diabetes. 56: 24-33.
33. Karagiannides, I., R. Abdou, A. Tzortzopoulou, P. J. Voshol, and K. E. Kypreos. 2008. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. FEBS J. 275: 4796-4809.
34. Takahashi, S., J. Suzuki, M. Kohno, K. Oida, T. Tamai, S. Miyabo, T. Yamamoto, and T. Nakai. 1995. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J. Biol. Chem. 270: 15747-15754.
35. Goudriaan, J. R., S. M. Espirito Santo, P. J. Voshol, B. Teusink, K. W. van Dijk, B. J. van Vlijmen, J. A. Romijn, L. M. Havekes, and P. C. Rensen. 2004. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45: 1475-1481. (Pubitemid 39006975)
36. Huang, Z. H., C. A. Reardon, and T. Mazzone. 2006. Endogenous ApoE expression modulates adipocyte triglyceride content and turnover. Diabetes. 55: 3394-3402. (Pubitemid 44923598)
37. Pouliot, M. C., J. P. Despres, S. Moorjani, P. J. Lupien, A. Tremblay, and C. Bouchard. 1990. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J. Lipid Res. 31: 1023-1029. (Pubitemid 20197804)
38. Feitosa, M. F., T. Rice, K. E. North, A. Kraja, T. Rankinen, A. S. Leon, J. S. Skinner, J. Blangero, C. Bouchard, and D. C. Rao. 2006. Pleiotropic QTL on chromosome 19q13 for triglycerides and adiposity: the HERITAGE Family Study. Atherosclerosis. 185: 426-432.
39. Volcik, K. A., R. A. Barkley, R. G. Hutchinson, T. H. Mosley, G. Heiss, A. R. Sharrett, C. M. Ballantyne, and E. Boerwinkle. 2006. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants. Am. J. Epidemiol. 164: 342-348. (Pubitemid 44297342)
40. Arbones-Mainar, J. M., L. A. Johnson, M. K. Altenburg, and N. Maeda. 2008. Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. Int. J. Obes. (Lond.). 32: 1595-1605.
41. Wu, K. K., and Y. Huan. 2007. Diabetic atherosclerosis mouse models. Atherosclerosis. 191: 241-249. (Pubitemid 46420447)
42. Park, L., K. G. Raman, K. J. Lee, Y. Lu, L. J. Ferran, Jr., W. S. Chow, D. Stern, and A. M. Schmidt. 1998. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4: 1025-1031. (Pubitemid 28417334)
43. Calkin, A. C., J. M. Forbes, C. M. Smith, M. Lassila, M. E. Cooper, K. A. Jandeleit-Dahm, and T. J. Allen. 2005. Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arterioscler. Thromb. Vasc. Biol. 25: 1903-1909. (Pubitemid 41243461)
44. Yi, X., and N. Maeda. 2006. alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes. 55: 2238-2244. (Pubitemid 44743620)
45. Gonzalez-Navarro, H., M. Vila-Caballer, M. F. Pastor, A. Vinue, M. F. White, D. Burks, and V. Andres. 2007. Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice. Front. Biosci. 12: 2291-2298.
46. Lyngdorf, L. G., S. Gregersen, A. Daugherty, and E. Falk. 2003. Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes. Cardiovasc. Res. 59: 854-862. (Pubitemid 38366241)
47. Wu, K. K., T. J. Wu, J. Chin, L. J. Mitnaul, M. Hernandez, T. Q. Cai, N. Ren, M. G. Waters, S. D. Wright, and K. Cheng. 2005. Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor. Atherosclerosis. 181: 251-259. (Pubitemid 41019605)
48. Taleb, S., O. Herbin, H. Ait-Oufella, W. Verreth, P. Gourdy, V. Barateau, R. Merval, B. Esposito, K. Clement, P. Holvoet, et al. 2007. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27: 2691-2698. (Pubitemid 350158924)
49. Gruen, M. L., V. Saraswathi, A. M. Nuotio-Antar, M. R. Plummer, K. R. Coenen, and A. H. Hasty. 2006. Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice. Atherosclerosis. 186: 54-64.
50. Chiba, T., S. Shinozaki, T. Nakazawa, A. Kawakami, M. Ai, E. Kaneko, M. Kitagawa, K. Kondo, A. Chait, and K. Shimokado. 2008. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis. 196: 68-75.